| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca29263a5a82ec115b3ac50147c80920 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4846
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76 |
| filingDate |
2001-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce3194b08728db6a6f3fcdd84f1f0112 |
| publicationDate |
2003-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1316319-A1 |
| titleOfInvention |
A novel gene therapy agent for haemophilia b and its preparation method |
| abstract |
The invention deals with the gene drugs for therapy Hemophilia B and its method ofnpreparation. It contains human source gene vector-FIX recombinant constructed usingnDNA sequence as leading sequence of therapy gene without important physiologicalnfunction-related gene on the short arms of human group D,G chromosomes or to whichnDNA sequence is homologous. This invention also provides the method of preparingngene drug. The therapy gene of gene drug for hemophilia B has a high stability ofnexpression, safety, high expression efficiency and no immunogenecity. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10612041-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10842853-B2 |
| priorityDate |
2000-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |